Aldesleukin Imaging in Viewing Tumor Growth in Patients With Stage IV Melanoma Receiving Ipilimumab or Pembrolizumab Therapy
Clinical trial NCT01789827 · COMPLETED
Trial details
- NCT number
- NCT01789827
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-01
- Primary completion
- 2018-06-27
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.